HCPCS Level IIdrugActive
J0716
Centruroides immune f(ab)
BETOS: O1E
Effective: 2013-01-01
Description
Injection, centruroides immune f(ab)2, up to 120 milligrams
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Anascorp
Manufacturer
Rare Disease Therapeutics, Inc.
HCPCS Dosage
UP TO 120 MG
Billing Units
1.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.